Company Filing History:
1 out of 1,588 
1 out of 1 Years Active: 1982
Title: Mamoru Kiyoki: Innovator in Bone Metabolism Regulation
Introduction
Mamoru Kiyoki is a notable inventor based in Ohme, Japan. He has made significant contributions to the field of medicine, particularly in the regulation of bone metabolism in warm-blooded animals. His innovative approach has the potential to impact the treatment of conditions such as osteoporosis.
Latest Patents
Kiyoki holds a patent for a method aimed at regulating the bone metabolism of warm-blooded animals. This method involves administering pharmaceutically effective amounts of 1.alpha., 24-dihydroxycholecalciferol (1.alpha., 24-DHCC) and 24,25-dihydroxycholecalciferol (24,25-DHCC). The patent outlines a pharmaceutical composition that includes these compounds along with a pharmaceutically acceptable carrier. The invention is particularly noteworthy as it provides a safe long-term treatment option for abnormal bone metabolism conditions, such as osteoporosis, without substantial adverse effects.
Career Highlights
Throughout his career, Mamoru Kiyoki has worked with prominent companies, including Teijin Limited and Teijin Pharmaceutical Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative methods in the field of bone metabolism.
Collaborations
Kiyoki has collaborated with esteemed colleagues, including Hiroyoshi Endo and Tatsuyuki Naruchi. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Mamoru Kiyoki's contributions to the field of bone metabolism regulation highlight his innovative spirit and dedication to improving medical treatments. His patent represents a significant advancement in the safe management of conditions like osteoporosis.